<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<script type="text/javascript">
	var methode = {};
	window.globe = window.globe || {};
	globe.version = '18279I1728';
</script>
<!-- /business auto:  -->
	<title>New chief aims to remake Sanofi Genzyme as growth engine for corporate parent - The Boston Globe</title>
<meta name="eomportal-instanceid" content="216"/>
<meta name="eomportal-id" content="1424338"/>
<meta name="eomportal-loid" content="4.3.2988983448"/>
<meta name="eomportal-uuid" content="9cdfe744-5e1a-11e7-9c40-8fa38db3e669"/>
<meta name="eomportal-lastUpdate" content="Tue Oct 10 02:08:08 EDT 2017"/>
<title>New chief aims to remake Sanofi Genzyme as growth engine for corporate parent - The Boston Globe</title>
<!-- Methode uuid: "9cdfe744-5e1a-11e7-9c40-8fa38db3e669" -->
<script src="//cdn.blueconic.net/bostonglobemedia.js"></script>

	<meta property="og:latitude" content="42.3736158" />
			<meta property="og:longitude" content="-71.1097335" />
			<meta property="og:city" content="Cambridge" />
			<meta property="og:state" content="MA" />
			<meta property="og:country" content="US" />
			<meta property="og:type" content="article"/>
	<meta property="og:description" content="Sanofi Genzyme, the largest Massachusetts biotech with about 5,000 workers, last week got a new president, Bill Sibold. He’s the first with no ties to the old Genzyme, an independent company that pioneered the rare disease business model and helped catalyze the local biotech boom before accepting a $20.1 billion buyout offer from Sanofi in 2011. "/>
	<meta property="og:title" content="New chief aims to remake Sanofi Genzyme as growth engine for corporate parent - The Boston Globe"/>
	<meta property="og:site_name" content="BostonGlobe.com" />
	<meta property="fb:admins" content="100001044693856" />
	<meta property="fb:admins" content="507486035" />
	<meta property="fb:app_id" content="103933749691726" />
	<meta property="fb:pages" content="5637143257" />
	<meta property="article:publisher" content="https://www.facebook.com/globe" />
	<link rel='apple-touch-icon' sizes='57x57' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-57x57.png'>
	<link rel='apple-touch-icon' sizes='60x60' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-60x60.png'>
	<link rel='apple-touch-icon' sizes='72x72' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-72x72.png'>
	<link rel='apple-touch-icon' sizes='76x76' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-76x76.png'>
	<link rel='apple-touch-icon' sizes='114x114' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-114x114.png'>
	<link rel='apple-touch-icon' sizes='120x120' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-120x120.png'>
	<link rel='apple-touch-icon' sizes='144x144' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-144x144.png'>
	<link rel='apple-touch-icon' sizes='152x152' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-152x152.png'>
	<link rel='apple-touch-icon' sizes='180x180' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/apple-touch-icon-180x180.png'>

	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-16x16.png' sizes='16x16'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-32x32.png' sizes='32x32'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-96x96.png' sizes='96x96'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-194x194.png' sizes='194x194'>
	<link rel='icon' type='image/png' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/favicon-192x192.png' sizes='192x192'>

	<link rel='mask-icon' href='/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/safari-pinned-tab.svg' color='#000000'>

	<link rel="shortcut icon" type="image/gif" href="/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/favicon.ico" />

	<meta name='msapplication-TileColor' content='#ffffff'>
	<meta name='msapplication-TileImage' content='//c.o0bg.com/rw/SysConfig/WebPortal/BostonGlobe/Framework/bg-images/png/favicon/mstile-144x144.png'>
	<meta name='theme-color' content='#ffffff'>

	<!--[if gte IE 9 ]>
	<meta name="application-name" content="Homepage"/>
	<meta name="msapplication-tooltip" content="This is the tooltip"/>
	<meta name="msapplication-starturl" content="/?comp=9"/>
	<![endif]-->

	<!--[if lte IE 8 ]>
	<meta name="application-name" content="Boston Globe"/>
	<meta name="msapplication-TileColor" content="#000000"/>
	<meta name="msapplication-TileImage" content="25a75e8d-4542-40a4-80aa-253aea7efc28.png"/>
	<link rel="stylesheet" media="print" href="/css/globe-ie-print.css?v=18279I1728" type="text/css" />
	<![endif]-->

	<meta property="twitter:account_id" content="95431448" />
<meta name="robots" content="noarchive" />
<meta name="description" content="Sanofi Genzyme, the largest Massachusetts biotech with about 5,000 workers, last week got a new president, Bill Sibold. He’s the first with no ties to the old Genzyme, an independent company that pioneered the rare disease business model and helped catalyze the local biotech boom before accepting a $20.1 billion buyout offer from Sanofi in 2011. " />
<meta name="keywords" content="Bill Sibold,Sanofi Genzyme,Henri Termeer,David Meeker,Olivier Brandicourt,specialty care, Bill George,Genzyme Corp, Sanofi Sa, Eli, & Co  Lilly, Amgen Inc, Harvard Business School, Medtronic Inc, Food and Drug Administration, Regeneron Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc, Twitter,Genzyme Corp|GENZ|NASDAQ, Eli, & Co|LLY|NYSE  Lilly, Amgen Inc|AMGN|NASDAQ, Medtronic Inc|MDT|NYSE, Regeneron Pharmaceuticals Incorporated|REGN|NASDAQ, Alnylam Pharmaceuticals Inc|ALNY|NASDAQ" />
<meta name="news_keywords" content="Bill Sibold,Sanofi Genzyme,Henri Termeer,David Meeker,Olivier Brandicourt,specialty care, Bill George,Genzyme Corp, Sanofi Sa, Eli" />
<meta property="og:url" content="https://www.bostonglobe.com/business/2017/06/30/new-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent/gGqXKi2C5FuGpaKkSzfBGN/story.html"/>
<link rel="canonical" href="https://www.bostonglobe.com/business/2017/06/30/new-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent/gGqXKi2C5FuGpaKkSzfBGN/story.html" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="BostonGlobe" />
<link rel="amphtml" href="https://www.bostonglobe.com/business/2017/06/30/new-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent/gGqXKi2C5FuGpaKkSzfBGN/amp.html" />
	<meta property="og:image" content="http://www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/07/02/BostonGlobe.com/Business/Images/sibold_crop.jpg" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
<meta name="viewport" content="width=device-width, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no" /> <!--[if gte IE 6]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css" rel="stylesheet"><![endif]-->
<!--[if !IE]><link href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-print.css?v=18279I1728" rel="stylesheet" media="only all"><![endif]-->
<!-- /business and story -->
<script src="/js/lib/jquery.js,dist/globe.js,dist/bglobesubs.js,dist/inline-newsletter.js,dist/brightcove-asset-loader.js,dist/globe-article.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" media="all" href="/css/html5reset.css,globe-globals.css,globe-masthead.css,globe-nav.css,globe-nav-menus.css,globe-main.css,globe-footer.css,globe-topic-nav.css,globe-comments.css?v=18279I1728"/>
<!-- oas_sitepage:/business/homepage -->
<!-- webtype is story section is  adPageType article oas_sitepage /business/homepage-->

<!--  lowestRank:  taxonomy:  section:  -->

		<!-- admode:  smode  -->
		<script type="text/javascript">
      var googletag = googletag || {};
      googletag.cmd = googletag.cmd || [];

      function oxDone() {
        var gads = document.createElement("script");
        gads.async = true;
        gads.type = "text/javascript";
        gads.src = "//www.googletagservices.com/tag/js/gpt.js";
        var node = document.getElementsByTagName("script")[0];
        node.parentNode.insertBefore(gads, node);
      }

      
      var OX_dfp_ads = [];

    </script>

    <!-- modAdunit: bostonglobe.com/business  -->
    <script>
    	  var globe = globe || {};
	      globe.dfp = {
	        networkCode: 61381659
	      };

          globe.dfp.keyValuePairs = {
            s1: 'bostonglobe.com',
            s2: 'business',
            s3: '',
            s4: '',
            pgtype: 'article',
            pageurl: '_business_2017_06_30_new-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent_gGqXKi2C5FuGpaKkSzfBGN_story_html',
            meta: "Bill_Sibold,Sanofi_Genzyme,Henri_Termeer,David_Meeker,Olivier_Brandicourt,specialty_care",
            weather: "",
            temp: "",
            aam: ""
        }
        globe.dfp.adUnit = 'bostonglobe.com/business';
    </script>
<!-- Facebook Pixel Code -->
<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()
{n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
;if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '884869448226452');
fbq('track', "PageView");</script>
<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=884869448226452&ev=PageView&noscript=1"
/></noscript>
<!-- End Facebook Pixel Code -->
</head>

<body itemscope itemtype="http://schema.org/WebPage" class='type-internal type-article section-business business type-business logged-out'>

<div id="contain">
<!-- type:EOM::CompoundStory autosection: section class:Business section:/business-->
<!-- topSection2 /business -->

<header class="bg-header clearfix">
	<div class="bg-header__subinfo bg-header__subinfo--tablet">
		<div class="js-user-subscribe" data-baseurl="https://www.bostonglobe.com"></div>
			</div>
	    <div id="smartbar" class="bg-header__smartbar" data-hide-on-load="true">
	       <a href="" class="bg-header__smartbar--message" onClick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar15,channel,prop1';s.linkTrackEvents='none';s.tl(this,'o','BG Header - Smart Bar_Marketing Gen');" data-logged-in-message='<span class="bg-header__smartbar--text-bold">Season Ticket</span> <span class="bg-header__smartbar--text">Listen now to the new sports podcast</span>' data-logged-in-link='https://bostonglobe.com/seasonticket' data-logged-out-message='<span class="bg-header__smartbar--text-bold">SUBSCRIBE NOW</span> <span class="bg-header__smartbar--text">Get unlimited access to Globe.com today</span>' data-logged-out-link='http://subscribe.bostonglobe.com/B6455/?p1=BGHeader_SmartBar_Marketing_Sub'>
	</a>
</div>
	<div class="bg-header__menus">
		<a href="#" class="bg-header__button bg-header__hamburger js-open-menu" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','BG Menu - Open');">Menu</a>
		<a href="/?p1=BGHeader_Logo" class="bg-header__button bg-header__home"></a>
	</div>

	<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/business?p1=BGHeader_SectionLink" class="bg-header__centerpiece bg-header__logo-wrapper">
               <div class="bg-header__logo"></div>
			<div class="bg-header__section-front">Business</div>

			</a>
		<nav class="bg-header__takeover" aria-hidden="true">
				<div class="bg-header__takeover-full-screen">
					<div class="bg-header__menu-wrapper">
	   					<div class="bg-header__close js-close-menu">
		   				</div>
		   				<a href="" class="bg-header__home"></a>

			   			<!-- Logged out Subinfo -->
						<div class="bg-header__subinfo">
	<div class="js-user-settings" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
			<div class="js-user-subscribe" data-location="menu" data-baseurl="https://www.bostonglobe.com"></div>
		</div>

<a href="/?p1=BGMenu_Logo" class="bg-header__logo"></a>

						<div class="bg-header__menu">
							<section class="bg-header__menu-left">
								<ul class="bg-header__sections">
									<li class="bg-header__section">
													<a href="/metro?p1=BGMenu" class="bg-header__link">Metro</a>
												</li>
											<li class="bg-header__section">
													<a href="/sports?p1=BGMenu" class="bg-header__link">Sports</a>
												</li>
											<li class="bg-header__section">
													<a href="/business?p1=BGMenu" class="bg-header__link">Business & Tech</a>
												</li>
											<li class="bg-header__section">
													<a href="/opinion?p1=BGMenu" class="bg-header__link">Opinion</a>
												</li>
											<li class="bg-header__section">
													<a href="/news/politics?p1=BGMenu" class="bg-header__link">Politics</a>
												</li>
											<li class="bg-header__section">
													<a href="/lifestyle?p1=BGMenu" class="bg-header__link">Lifestyle</a>
												</li>
											<li class="bg-header__section">
													<a href="/arts?p1=BGMenu" class="bg-header__link">Arts</a>
												</li>
											<li class="bg-header__section">
													<a href="http://www.boston.com/section/cars" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Cars');">
														Cars</a>
												</li>
											<li class="bg-header__section">
													<a href="http://realestate.boston.com" class="bg-header__link"
														target="_blank"
														onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Menu - Nav - Real Estate');">
														Real Estate</a>
												</li>
											</ul>
							</section>
							<section class="bg-header__menu-right">
								<div class="bg-header__recommended">
									<p class="bg-header__recommended-header">
										Most popular on BostonGlobe.com
									</p>
									<p class="bg-header__recommended-subhead">Based on what you&#39;ve read recently, you might be interested in theses stories</p>
								</div>
								<div class="bg-header__suggestions">
		<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/lifestyle/names/2017/10/09/report-matt-damon-helped-kill-earlier-new-york-times-story-about-harvey-weinstein/2TDJnvLT0eDq9HhuvdmXjP/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/09/19/BostonGlobe.com/Lifestyle/Images/06196800.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Report: Matt Damon helped kill earlier New York Times story about Harvey Weinstein</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/sports/redsox/2017/10/09/shaughnessy/EK3NwkqZneeTdMOnc8qr0N/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/ReceivedContent/Images/Grossfeld4ALDS2.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Dan Shaughnessy: Red Sox stars did not deliver when it mattered most</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/business/2017/10/09/homeowner-deck-nightmare/C7IN6Ej7pNmNASrIz7ormI/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/09/BostonGlobe.com/Business/Images/consumerwiggs_Home_02.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Homeowner’s deck nightmare</figcaption>
	 					</a>
		   			</figure>
				<figure class="bg-header__suggestion">
					<a href="//www.bostonglobe.com/news/nation/2017/10/09/suspect-large-after-texas-tech-officer-shot-killed/oGiaX9f3fAhrj8ZgAh5h7I/story.html?p1=BGMenu_Article" class="bg-header__link">
				          <picture class="bg-header__image-wrapper">
							<img class="bg-header__suggestion-image" src="//www.bostonglobe.com/rf/image_585w/Boston/2011-2020/2017/10/10/BostonGlobe.com/National/Images/AP17283084250118.jpg"/>
						</picture>
						<figcaption class="bg-header__suggestion-title">Suspect in custody after fatal shooting of Texas Tech officer</figcaption>
	 					</a>
		   			</figure>
				</div>
<form action="/queryResult/search" class="bg-header__search" method="get" role="search">
						        <div class="search-inputs">
									<input type="text" class="bg-header__input" id="q" placeholder="Search BostonGlobe.com" role="search" name="q">
								</div>
							</form>
							</section>
							<ul class="bg-header__more-sections">
								<li class="bg-header__section">
										<a href="/todayspaper?p1=BGMenu_Subnav" class="bg-header__link">Today's Paper</a>
									</li>
								<li class="bg-header__section">
										<a href="/magazine?p1=BGMenu_Subnav" class="bg-header__link">Magazine</a>
									</li>
								<li class="bg-header__section">
										<a href="/metro/obituaries?p1=BGMenu_Subnav" class="bg-header__link">Obituaries</a>
									</li>
								<li class="bg-header__section">
										<a href="http://www.boston.com/weather?p1=BGMenu_Subnav" class="bg-header__link">Weather</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/comics?p1=BGMenu_Subnav" class="bg-header__link">Comics</a>
									</li>
								<li class="bg-header__section">
										<a href="/lifestyle/crossword?p1=BGMenu_Subnav" class="bg-header__link">Crossword</a>
									</li>
								<li class="bg-header__section">
										<a href="/news/bigpicture?p1=BGMenu_Subnav" class="bg-header__link">The Big Picture</a>
									</li>
								</ul>
						</div>
						<aside class="bg-header__pop-up" aria-hidden="true">
					   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
					   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
						   		<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Digital Access</p>
					   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
								<a href="https://subscribe.bostonglobe.com/B3853/?eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>
								<a href="https://subscribe.bostonglobe.com/B3853/?rc=WW20167D&eglobe_rc=WW20167D&p1=BGMenu_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe Digital');">Subscribe</a>				   			</section>
					   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
					   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
					   			<p class="bg-header__sub-title">Home Delivery</p>
					   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
								<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
		   						<a href="https://subscribe.bostonglobe.com/B8554/?rc=WW011964&globe_rc=WW011964&p1=BGMenu_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG Menu Modal';s.events='event13';s.tl(this,'o','BG Menu – Subscribe HD');">Subscribe</a>
					   		</section>
				   			<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGMenu_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Menu Modal';s.events='event15';s.tl(this,'o','BG Menu Modal - Log In');">Members Sign In</a></span>
				   		</aside>
	   				</div>
	   			</div>
   			</nav>



   	<aside class="bg-header__pop-up" aria-hidden="true">
   		<div class="bg-header__close-pop-up js-close-pop-up"></div>
   		<div class="bg-header__caret-wrapper"><div class="bg-header__caret"></div></div>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--digital">
   			<img src="/img/masthead/lockup.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Digital Access</p>
   			<p class="bg-header__promo-text">99 cents a week for the first 4 weeks</p>
		    <a href="https://subscribe.bostonglobe.com/B3605/?eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B3605/?rc=WW20145D&eglobe_rc=WW20145D&p1=BGHeader_DigitalSubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	Digital');">Subscribe</a>

   		</section>
   		<section class="bg-header__pop-up-section bg-header__pop-up-section--delivery">
   			<img src="/img/masthead/newspaper.png" class="bg-header__sub-img"/>
   			<p class="bg-header__sub-title">Home Delivery</p>
   			<p class="bg-header__promo-text">Save 50% off the regular rate</p>
			<a href="//homedelivery.bostonglobe.com/hd/26/order/zip/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-mobile" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
			<a href="https://subscribe.bostonglobe.com/B0004/?rc=WW011964&globe_rc=WW011964&p1=BGHeader_HomeDeliverySubscription" class="bg-header__sub-button bg-header__display-desktop" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar25,events';s.linkTrackEvents='event13';s.eVar25='BG	Header Modal';s.events='event13';s.tl(this,'o','BG	Header	– Subscribe	HD');">Subscribe</a>
   		</section>
   		<span class="bg-header__sub-login">Already a subscriber? <a href="https://www.bostonglobe.com/login?p1=BGHeader_Login_Link" class="bg-header__sub-click" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='eVar27,events';s.linkTrackEvents='event15';s.eVar27='BG Header Modal';s.events='event15';s.tl(this,'o','BG Header Modal - Log In');">Members Sign In</a></span>
   	</aside>

</header>
<!-- story_default.jpt, story id:ae54edde-5df8-11e7-8b1b-beb6e0890464 path:/Boston/2011-2020/2017/06/26/BostonGlobe.com/Business/Stories -->

		<div class="ad billboard" id="ad_outofpage2"></div>  <div class="ad billboard" id="ad_billboard"></div>  <div class="mod live-update">
			</div>

		<main id="main" role="main" class="eptClick">
			<article class="article" itemscope="itemscope"
				itemtype="http://schema.org/NewsArticle">
				<meta itemprop="inLanguage" content="en-US" />
				<meta itemprop="genre" content="news" />
				<meta itemprop="articleSection" content="Business" />
				<!-- Headline Section -->
				<header>
	<div class="header new">
	<h1 class="main-hed" itemprop="headline">New chief aims to remake Sanofi Genzyme</h1>
	</div>
	
	</header>
<div class="article-body">
					<!-- position:Top -->
<!--
METADATA FOR EMTAF
      <headline>New chief aims to remake Sanofi Genzyme</headline>
      <source>Globe Staff</source>
      <teasetext>Sanofi Genzyme&amp;lsquo;s new president, Bill Sibold, describes his aim at Sanofi Genzyme succinctly: &amp;ldquo;We&amp;rsquo;re planning for growth.&amp;rdquo;</teasetext>
      <byline>By Robert Weisman</byline>
      <date>20170701010000</date>
-->

<aside class="tools">
	<ul class="Top tools primary-tools">
		<!-- imgAltCaption: New Sanofi Genzyme president Bill Sibold is the first without any ties to Henri Termeer (inset) to lead the company. -->
		<li class="email">
	      <a class="bg-button--email email" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Email_Top');" data-omniture="BG Article Share Tools - Email - Top" target="_blank" title="Share via E-mail" aria-label="Share via E-mail" href="#"><span class="bg-icon--email">E-Mail</span></a>
	      <div class="email-form">
				<h4>Share via e-mail</h4>
				<div class="email-error"></div>
				<form action="" method="post">
					<input type="hidden" id="story_url-Top" name="story_url" value="http://www.bostonglobe.com/business/2017/06/30/new-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent/gGqXKi2C5FuGpaKkSzfBGN/story.html"/>
					<p>
						<label for="email-to-primary-Top">To</label>
						<input type="text" name="email-to-primary" id="email-to-primary-Top" placeholder="Separate multiple addresses with a comma" />
					</p>
					<p>
						<label for="email-mssg-primary-Top">Add a message</label>
						<textarea name="email-mssg-primary" id="email-mssg-primary-Top" maxlength="80" placeholder="80 character limit"></textarea>
					</p>
					<p>
						<label for="email-from-primary-Top">Your e-mail</label>
						<input type="text" name="email-from-primary" id="email-from-primary-Top" />
					</p>
					<input type="submit" value="Send" class="bg-button" onClick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Send_Top');"/>
				</form>
			</div><!-- /end .email-form -->
	    </li>
	    <li>
	      <a class="bg-button--fb" data-omniture="BG Article Share Tools - Facebook - Top" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25&amp;t=New chief aims to remake Sanofi Genzyme" target="_blank" title="Share on Facebook" aria-label="Share on Facebook"><span class="bg-icon--fb">Facebook</span></a>
	    </li>
	    <li>
	      <a class="bg-button--twitter" data-omniture="BG Article Share Tools - Twitter - Top" href="http://twitter.com/intent/tweet?text=New chief aims to remake Sanofi Genzyme&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter" aria-label="Share on Twitter"><span class="bg-icon--twitter">Twitter</span></a>
	    </li>
	    <li>
			<a class="bg-button--gplus" data-omniture="BG Article Share Tools - Google+ - Top" href="https://plus.google.com/share?url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25%26s_campaign%3dsm_gp%26hl=en-US" target="_blank" title="Share on Google+" aria-label="Share on Google+"><span class="bg-icon--gplus">Google+</span></a>
				</li>
	    <li>
	      <a class="bg-button--linkedin" data-omniture="BG Article Share Tools - Linkedin - Top" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25&amp;title=New chief aims to remake Sanofi Genzyme&amp;summary=Sanofi+Genzyme%26amp%3Blsquo%3Bs+new+president%2C+Bill+Sibold%2C+describes+his+aim+at+Sanofi+Genzyme+succinctly%3A+%26amp%3Bldquo%3BWe%26amp%3Brsquo%3Bre+planning+for+growth.%26amp%3Brdquo%3B" target="_blank" title="Share on LinkedIn" aria-label="Share on LinkedIn"><span class="bg-icon--linkedin">LinkedIn</span></a>
	    </li>
	</ul>
	<a href="#comments" class="js-comments-toggle bg-button--generic">
		  <span class="bg-icon-comment-dark bg-icon--small"></span>
		  <span class="js-comment-count"></span> <span class="js-comment-count-label bg-visuallyhidden">Comments</span>
		</a>

	<a class="bg-button--generic bg-button--print" onclick="var s=s_gi('nytbostonglobecom');s.tl(this,'o','ArticleTools_Print_Top')" href="javascript:print();">
			<span class="bg-icon--print bg-icon--small"></span>
			<span class="bg-visuallyhidden">Print</span></a>
		</aside>
<div class="sticky-tools">
		<a class="sticky-tools__button sticky-tools__button--home" href="/?p1=BGHeader_Logo_Sticky">
		    <span>The Boston Globe</span>
		</a><a class="sticky-tools__button sticky-tools__button--share tw" data-omniture="BG Article Share Tools - Twitter - Sticky" href="http://twitter.com/intent/tweet?text=New chief aims to remake Sanofi Genzyme&amp;url=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;via=BostonGlobe" target="_blank" title="Share on Twitter">
		    <span>Tweet</span>
		</a><a class="sticky-tools__button sticky-tools__button--share fb" data-omniture="BG Article Share Tools - Facebook - Sticky" href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.bostonglobe.com%2Fbusiness%2F2017%2F06%2F30%2Fnew-chief-aims-remake-sanofi-genzyme-growth-engine-for-corporate-parent%2FgGqXKi2C5FuGpaKkSzfBGN%2Fstory.html%3Fevent%3Devent25%3Fevent%3Devent25&amp;tNew chief aims to remake Sanofi Genzyme" target="_blank" title="Share on Facebook">
		    <span>Share</span>
		</a><a class="sticky-tools__button sticky-tools__button--share sticky-comments js-sticky-comments" href="#comments">
		    <span></span>
		    <p class="js-comment-count sticky-comments-count"></p>
		    <p class="js-comment-count-label sticky-comments-count-label"></p>
		</a>
		<div class="sticky-tools__button sticky-tools__button--top js-back-to-top"></div>
	</div>
<!-- Header Tabs Section -->
					<figure itemprop="associatedMedia" itemscope itemtype="http://schema.org/ImageObject" class="figure lead-figure full">
		<img  itemprop="contentUrl" src="//www.bostonglobe.com/rf/image_r/Boston/2011-2020/2017/07/02/BostonGlobe.com/Business/Images/2000_genzyme_leader3.r.jpg" data-fullsrc="//c.o0bg.com/rf/image_960w/Boston/2011-2020/2017/07/02/BostonGlobe.com/Business/Images/2000_genzyme_leader3.jpg" alt="New Sanofi Genzyme president Bill Sibold is the first without any ties to Henri Termeer (inset) to lead the company."/>
		<figcaption class="figcaption">
			<meta itemprop="creator" content="Jonathan Wiggs" />
			<p class="credit">Jonathan Wiggs/Globe Staff</p>
			<p itemprop="description caption">New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company.</p>
		</figcaption>
	</figure>	
<div class="byline">
	<b class="author"><!---->By <a class="" title="More Stories by Robert Weisman" href="/staff/weisman" rel="author"><span itemprop="name">Robert Weisman</span></a></b>
	Globe Staff&nbsp;
	<time itemprop="datePublished" datetime="2017-07-01 01:00">July 01, 2017</time>
	<p></p>
	<p></p>
</div><div class="article-text" itemprop="articleBody">
						<!-- leading video or graphic -->
						<!-- inside story_update.jpt -->
<!-- In Story Photo or Graphic Section -->
							<!-- paragraphs 23 leadingContainer photo
										leadingShape horizontal hasRBox false -->
									<!----><p>CAMBRIDGE &mdash; When drug giant Sanofi SA restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger &ldquo;specialty care&rdquo; portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.</p><p>Last week, Sanofi Genzyme &mdash; still the largest Massachusetts biotech, with about 5,000 workers &mdash; also got a new president, Bill Sibold. He&rsquo;s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi&rsquo;s $20.1 billion takeover offer in 2011.</p><div class="inline-newsletter" data-exact-target-ID="20712964" data-mailing-list-name="Talking Points" data-is-amp="" data-section="/business">
  <div class="inline-newsletter__network-error"></div>
  <div class="inline-newsletter__copy">
    <div class="inline-newsletter__title">
      Get <span class="inline-newsletter__bold">Talking Points</span> in your inbox:
    </div>
    <div class="inline-newsletter__description">
        An afternoon recap of the day’s most important business news, delivered weekdays.</div>
    </div>
  <form class="inline-newsletter__content" method="post">
    <div class="inline-newsletter__error-text"></div>
    <input placeholder="Enter email address" type="text" id="inline-newsletter-email-input" class="inline-newsletter__input">

    <div class="inline-newsletter__button-container">
      <button class="inline-newsletter__button">
        <span class="inline-newsletter__button-text">Sign Up</span>
      </button>
      <div class="inline-newsletter__spinner"></div>
    </div>
  </form>
  <div class="inline-newsletter__thanks">
    Thank you for signing up!
    <a href="/newsletters?p1=Article_inline-newsletterWidget_ThankYou_Link" class="inline-newsletter__link">Sign up for more newsletters here</a>
    </div>
</div>

<p class="skip-nav article-more">
	<a>Advertisement</a>
	</p>

<div class="ad aside" id="ad_bigbox1"></div>  <a id="skip-target1"></a>

<p>Sibold, a 50-year-old Canadian native who played professional tennis briefly after college, previously worked for drug companies Eli Lilly &amp; Co., Amgen Inc., and cross-town rival Biogen Inc. He describes his aim at Sanofi Genzyme succinctly: &ldquo;We&rsquo;re planning for growth.&rdquo; And he cites &ldquo;two things that are core to legacy Genzyme .&nbsp;.&nbsp;. science and patients.&rdquo;</p><p>But his challenge won&rsquo;t be the same as those faced by his predecessors, the legendary Henri Termeer, who built Genzyme into a biotech pillar during nearly three decades at the helm, and Termeer&rsquo;s protege, David Meeker, who led the post-buyout transition. Sibold will be managing not only Sanofi&rsquo;s fastest growing division &mdash; an expansion &ldquo;engine&rdquo; in the parlance of industry analysts &mdash; but also the expectations of its corporate overseers in Paris. </p><p>Sibold is quick to pay homage to Meeker, who hired and groomed him at Sanofi Genzyme, and Termeer, with whom he huddled last month about a week before Termeer&rsquo;s sudden death. But he talks most enthusiastically about the strategy of his corporate boss, Sanofi&rsquo;s new chief executive Olivier Brandicourt, who engineered the 2015 reorganization that shrank the sprawling Sanofi into five distinct &ldquo;global business units&rdquo; managing different sets of products.</p><!-- total:0 -->

<p>&ldquo;It&rsquo;s been his vision,&rdquo; Sibold said of Brandicourt, who significantly expanded the number of products and medical specialties under Genzyme&rsquo;s umbrella. &ldquo;One of the things Olivier believes is important is having focus. We&rsquo;re a diversified human health care company. The whole idea is to be able to focus to be successful in each of these [therapeutic] areas.&rdquo;</p><p>Sibold calls the division&rsquo;s larger mission &ldquo;a vote of confidence&rdquo; from Sanofi.</p><!--  working ad -->
<p class="skip-nav article-more">
	<a>Advertisement</a>
	<!-- <a href="#skip-target2">Continue reading below</a> -->
</p>
<!-- adLayerPath: /Boston/Production/BostonGlobe.com/WebPages/Homepage/homepage.ad-layer.story-asset.dwp -->
<div class="ad aside" id="ad_bigbox2"></div>  <a id="skip-target2"></a>

<p>Termeer, a towering figure in the biotech industry, set a high bar for any successor holding the top job at the company he built. Sibold was invited for a chat in the retired executive&rsquo;s office on the Boston waterfront the week before his death. At that meeting, Termeer talked about the company&rsquo;s history and exuded &ldquo;pure passion to help patients, to solve a problem,&rdquo; recalled Sibold, who never worked with Termeer. The two had planned to consult on an ongoing basis, he said. </p><p>Noting that Termeer ran Genzyme and steered its strategy locally, industry veteran Bill George, a senior fellow at Harvard Business School and former chief executive of medical device maker Medtronic Inc., said Sibold will play a fundamentally different role.</p><p>Any business group executive who reports to corporate headquarters is &ldquo;a division head, an operator who will run the business,&rdquo; George said. &ldquo;There are big shoes to fill at Genzyme, but it&rsquo;s not the same shoes. The key strategic decisions are going to be made in France, let&rsquo;s not kid ourselves. They&rsquo;ll give you a budget and say how much you can spend on research.&rdquo;</p><div class="wide">
<img alt="Amy Richards, principal research associate, at Sanofi Genzyme&rsquo;s Framingham lab." data-fullsrc="//c.o0bg.com/rf/image_1920w/Boston/2011-2020/2017/06/21/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met3.jpg" src="//c.o0bg.com/rf/image_r/Boston/2011-2020/2017/06/21/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met3.r.jpg"><div class="figcaption">
<p class="credit">Barry Chin/Globe Staff</p>
<p>Amy Richards, principal research associate, at Sanofi Genzyme&rsquo;s Framingham lab.</p>
</div>
</div><p>Sibold earned his stripes at the Sanofi Genzyme division by building from scratch a multiple sclerosis business that has launched two new treatments for the neurological disease &mdash; including the oral drug Aubagio, which has become a top-selling product. The franchise, under Sibold, has emerged as a competitor to Biogen, the global leader in MS medicines.</p><p>Now he will oversee a broader line of about 20 products. Since the Sanofi restructuring, that line now includes not only legacy Genzyme therapies that treat rare genetic disorders such as Gaucher and Fabry diseases, but also drugs to treat prostate cancer and immunological diseases such as atopic dermatitis and rheumatoid arthritis, and help prevent kidney transplant rejection.</p><p>Sanofi has made a big bet that Sanofi Genzyme can draw on its heritage of innovation to shepherd a new generation of specialty care products onto the market, said Seamus Fernandez, analyst at Boston health care investment bank Leerink Partners.</p><p>Among the products in the works are experimental treatments for multiple myeloma, squamous cell carcinoma, asthma, and Parkinson&rsquo;s disease.</p><p>Sibold &ldquo;has a hugely important job,&rdquo; Fernandez said. &ldquo;They&rsquo;ve taken all their specialty portfolio assets, where you&rsquo;re addressing a smaller market, and they&rsquo;ve domiciled them with the Genzyme division. The biggest challenge will be to sustain and maintain the focus on the legacy Genzyme portfolio, because they are profitable products, while advancing the new products.&rdquo; </p><p>While all Sanofi Genzyme drugs are prescribed by specialist physicians rather than primary care doctors, they vary widely in how they work and address a range of patient populations. Cerezyme, an infusion to treat the enzyme deficiency Gaucher disease, targets a global population of about 33,000 patients. By contrast, the injectable rheumatoid arthritis drug Kevzara has the potential to treat about 70 million patients around the world.</p><p>Dupixent, an injectable drug for atopic dermatitis, a skin condition causing intense itching and bleeding, was approved in March by the Food and Drug Administration and is projected to generate annual sales of up to $5 billion by 2020, according to stock analysts. That drug, developed with Regeneron Pharmaceuticals Inc. of Tarrytown, N.Y., could treat as many as 300,000 patients in the United States and become one of Sanofi Genzyme&rsquo;s largest. </p><p>Sanofi Genzyme priced Dupixent at $37,000 per patient, far less than the hundreds of thousands of dollars it charges for enzyme replacement medicines. An independent watchdog group, the Institute for Clinical and Economic Review &mdash; which the company consulted before setting Dupixent&rsquo;s price &mdash; said &ldquo;it aligns fairly with the added benefit it brings to patients.&rdquo;</p><div class="wide">
<img alt="Sanofi scientist Jennifer Clarke-Matthews (above), with Pablo Sardi, director of research and development, examined brain tissue from a mouse. Sanofi researchers are studying an investigational treatment for patients with Parkinson&rsquo;s disease. " data-fullsrc="//c.o0bg.com/rf/image_1920w/Boston/2011-2020/2017/07/01/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met1[1]-6739.jpg" src="//c.o0bg.com/rf/image_r/Boston/2011-2020/2017/07/01/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met1[1]-6739.r.jpg"><div class="figcaption">
<p class="credit">Barry Chin/Globe Staff</p>
<p>Sanofi scientist Jennifer Clarke-Matthews (above), with Pablo Sardi, director of research and development, examined brain tissue from a mouse. Sanofi researchers are studying an investigational treatment for patients with Parkinson&rsquo;s disease. </p>
</div>
</div><p>But because they sell specialty treatments for smaller groups of patients, Sanofi Genzyme executives can expect to be under a spotlight as a backlash against high prescription drug prices grows in the United States. Sibold acknowledges that he, like Meeker before him, will be called on to defend Sanofi Genzyme&rsquo;s prices. &ldquo;This is the responsibility of the company and the community,&rdquo; he said. &ldquo;We have to do a better job communicating the value we bring to society.&rdquo;</p><p>The alliance with Regeneron is one of several partnerships that are becoming increasingly important to Sanofi Genzyme, according to Sibold. It also collaborates with nearby Alnylam Pharmaceuticals Inc., which is developing drugs based on a gene-silencing technology, and Voyager Therapeutics Inc., another local company experimenting with gene therapies. Sanofi Genzyme has invested in both companies, and Sibold won&rsquo;t rule out additional deals.</p><p>&ldquo;There&rsquo;s always the potential for other partnerships,&rdquo; he said. &ldquo;We are looking to develop our pipeline.&rdquo;</p><p>Sanofi, which has added hundreds of jobs over the past two years, is likely to continue expanding in Massachusetts over the long term and next year plans to move its headquarters from 500 Kendall St. to a new location on 50 Binney St., about a block away.</p><p>Sibold downplays the importance of the move, saying, &ldquo;buildings are great but the focus for us is on patients.&rdquo;</p><div class="wide">
<img alt="Kasey Jackson (right), postdoctoral fellow, prepped samples for analysis." data-fullsrc="//c.o0bg.com/rf/image_1920w/Boston/2011-2020/2017/07/01/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met6[1].jpg" src="//c.o0bg.com/rf/image_r/Boston/2011-2020/2017/07/01/BostonGlobe.com/Business/Images/Chin062117SanofiGenzyme_Met6[1].r.jpg"><div class="figcaption">
<p class="credit">Barry Chin/Globe Staff</p>
<p>Kasey Jackson (right), postdoctoral fellow, prepped samples for analysis.</p>
</div>
</div><!----><p></p><i>Robert Weisman can be reached at <a class="a" href="mailto:robert.weisman@globe.com">robert.weisman@globe.com</a>. Follow him on Twitter <a class="a" href="http://twitter.com/GlobeRobW">@GlobeRobW</a>.</i><!-- inside story_update.jpt -->
</div><!-- end article-text -->
					<!-- Story tools -->
						<!-- for comments -->
					<footer class="article-footer" role="contentinfo">
<script>var uuid = 'ae54edde-5df8-11e7-8b1b-beb6e0890464';</script>
<div id="comments">
	<div id="comments-content" class="ugc-comments comments">
		<div class="loading-message" id="loading-comments">
			Loading comments...
			 </div>
	</div>
</div>
<div id="newcomments"></div>
</footer>
</div><!-- ends article-body -->
				<!-- place for ads and trending -->
				<nav id="section-nav" class="section-nav trending-nav" data-sectionname="/business">
     <h3>Top 10 Trending Articles</h3>
      <nav>
        <ul class="bg-tabs-sidebar bg-33-33-33">
          <li><a class="here js-show-tab" href="#most-viewed">Most Viewed</a></li>
          <li><a class="js-show-tab" href="#most-commented">Most Commented</a></li>
          <li><a class="js-show-tab" href="#most-shared">Most Shared</a></li>
        </ul>
      </nav>

      </nav>

  <div id="ad_outofpage1" class="ad outofpage1"></div>
</article>
		</main>
		<!-- Page footer -->
<div class="subscription-banner">
	<a class="subscription-banner__link" href="http://subscribe.bostonglobe.com/B0565?p1=BGFooter_DigitalSubscription_Banner">
		<span class="subscription-banner__title">Real journalists. Real journalism. </span>
		<span class="subscription-banner__cta" >Subscribe to The Boston Globe today.</span>
	</a>
</div>
<footer class="site-footer" role="contentinfo">
	<div class="site-footer__content">
		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">My Account</h3></li>
			<li class="site-footer__list-item"><a href="https://manage.bostonglobe.com/cs/mc/login.aspx?p1=BGFooter" class="site-footer__link">Manage my Account</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobe.com/bgcs" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Download Customer Service App');">Mobile Customer Service</a></li>
			<li class="site-footer__list-item"><a href="/newsletters?p1=BGFooter_Newsletters" class="site-footer__link">Sign Up For Newsletters</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Contact</h3></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/home?p1=BGFooter" class="site-footer__link">Help</a></li>
			<li class="site-footer__list-item"><a href="https://bostonglobe.custhelp.com/app/answers/list?p1=BGFooter" class="site-footer__link">FAQs</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/stafflist?p1=BGFooter" class="site-footer__link">Globe newsroom</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Home Page');">Advertise</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">Social</h3></li>
			<li class="site-footer__list-item"><a href="https://www.facebook.com/globe" class="site-footer__link">Facebook</a></li>
			<li class="site-footer__list-item"><a href="https://twitter.com/#!/BostonGlobe" class="site-footer__link">Twitter</a></li>
			<li class="site-footer__list-item"><a href="https://plus.google.com/108227564341535363126/about" class="site-footer__link">Google+</a></li>
		</ul>

		<ul class="site-footer__list">
			<li class="site-footer__list-item"><h3 class="site-footer__heading">More</h3></li>
		    <li class="site-footer__list-item"><a href="http://epaper.bostonglobe.com/launch.aspx?pbid=2c60291d-c20c-4780-9829-b3d9a12687cf" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - EPaper launch');">ePaper</a></li>
			<li class="site-footer__list-item"><a href="http://nieonline.com/bostonglobe/" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - News In Education');">News in Education</a></li>
			<li class="site-footer__list-item"><a href="https://secure.pqarchiver.com/boston-sub/no_default.html?ss=1&amp;url=%2Fboston-sub%2Fadvancedsearch.html" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - Public Archives');">Archives</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/privacy?p1=BGFooter" class="site-footer__link">Privacy policy</a></li>
			<li class="site-footer__list-item"><a href="/tools/help/terms-service?p1=BGFooter" class="site-footer__link">Terms of service</a></li>
			<li class="site-footer__list-item"><a href="/termsofpurchase?p1=BGFooter" class="site-footer__link">Terms of purchase</a></li>
			<li class="site-footer__list-item"><a href="https://www.bostonglobemedia.com/careers" class="site-footer__link" onclick="var s=s_gi('nytbostonglobecom');s.linkTrackVars='channel,prop1,eVar15';s.linkTrackEvents='none';s.tl(this,'o','BG Footer - BGM Careers');">Work at Boston Globe Media</a></li>
		</ul>
		<p class="site-footer__copyright">&copy; 2017 Boston Globe Media Partners, LLC</p>
	</div>
</footer>

<script type="text/javascript" src="//tags.mediaforge.com/js/4600"></script>

<script type="text/javascript">
	var google_conversion_id = 1071256246;
	var google_custom_params = window.google_tag_params;
	var google_remarketing_only = true;
</script>
<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js" ></script>
<noscript>
	<div style="display:inline;">
		<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/1071256246/?value=0&amp;guid=ON&amp;script=0"/>
	</div>
</noscript><div class="ad ad-slot-c" id="EXTRA"></div><!-- Tracking -->
<!-- stubView3 =  -->
<!-- sPageNameExt: New chief aims to remake Sanofi Genzyme as growth engine for corporate parent -->
		

		
			
			
				
			
		
		
		

		
		
			
				
			
		

		
			
		

	
	
	
	
	
	
	








	
		
	
	




<!-- sectionpath /business -->



<!-- pageTitle:  -->

<!-- Determine sprop_3 -->




	
		
	
	
		
		
		<!-- authors: Robert Weisman -->
	

<script>
	var sPageName = (typeof sPageNameOverride != 'undefined') ? sPageNameOverride : 'Business | New chief aims to remake Sanofi Genzyme as growth engine for corporate parent';
	//if (typeof sPageNameOverride != 'undefined') {
	//	sPageName = sPageNameOverride;
	//}
	var sChannel = (typeof sChannelOverride != 'undefined') ? sChannelOverride : 'Business';
	//var sChannel  = 'Business';
	var sProp1    = 'Business';
	var sProp3    = 'Robert Weisman';
	var sProp4    = 'Standard';
	//var sProp6    = 'Article Page | Globe Story';
	var sProp6    = (typeof sProp6Val != 'undefined') ? sProp6Val : 'Article Page | Globe Story';
	var sProp8	  = '07/01/2017 01:00:00 AM';
	var sProp16    = 'none';
	var sProp67	  = 'ae54edde-5df8-11e7-8b1b-beb6e0890464';
	var sProp68	  = 'New chief aims to remake Sanofi Genzyme';
	var sProp6a = sProp6;
	var sProp1a = sProp1;
	var sPageNamea = sPageName;
	var taxonomies = '';
	var sChannela = sChannel;
	  if ( methode.showPaywall ) {
	    sChannel  = 'Member Center';
	    sProp1    = 'Member Center | BGC Registration';
	    if ( $(window).width() <= 768 ) {
	      // assume mobile
	      sPageName = 'Member Center | BGC Registration | Fullpage Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Fullpage';
	    } else {
	      // assume desktop
	      sPageName = 'Member Center | BGC Registration | Modal Paywall Challenge';
	      sProp6    = 'BGC Registration Page - Modal';
	    }
	  }
	globe.extend(globe.analytics.omniture, {
	  'pageType' : '',
	  'pageName' : sPageName,
	  'channel'  : sChannel,
	  'prop1'    : sProp1,
	  'prop3'    : sProp3,
	  'prop4'    : sProp4,
	  'prop6'    : sProp6,
	  'prop8'    : sProp8,
	  'prop16'    : sProp16,
	  
		'prop35' : 'logged out',
		'eVar20' : 'logged out',
   		'prop42' : 'Metered',
   		'eVar42' : 'Metered',

	  'eVar16'   : 'none',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar41'   : 'BostonGlobe.com',
	  'eVar67'   : sProp67,
	  'prop67'    : sProp67,
	  'prop68'    : sProp68,
	  'list2'	 : taxonomies,
	  'WT omnituretracking.tag' : 'story'
	});
</script>

<noscript>
	<img src="http://newyorktimes.112.2o7.net/b/ss/nytbostonglobecom/1/H.23.3--NS/0?pageName=News%20%7C%20BGC%20Homepage&amp;ch=News&amp;c1=News%20%7C%20BGC%20Homepage&amp;c6=BGC%20Homepage&amp;c41=BostonGlobe.com&amp;v41=BostonGlobe.com" height="1" width="1" border="0" alt="" />
</noscript>


</div>
<script src="/js/dist/globe-sticky-tools.js,dist/globe-sticky-masthead.js,dist/globe-topic-nav.js,dist/globe-analytics.js,dist/lib/modernizr.custom.min.js?v=18279I1728"></script>
<link rel="stylesheet" type="text/css" href="//meter.bostonglobe.com/css/style.css">
<script src="//meter.bostonglobe.com/js/meter.js"></script>
<script src="/js/dist/globe-header.js,dist/globe-blueconic.js,dist/chartbeat.js,dist/continue-reading.js,dist/globe-subscription-banner.js,dist/globe-adcatalog.js,dist/globe-adinclude.js,dist/globe-comments.js,dist/globe-masthead.js?v=18279I1728"></script>
<script type="text/javascript">
	(function() {
		if (typeof window.meterObject !== 'undefined') {
			
			// Change the meter base URL (this allows all campaign links to be relative) for this particular environment.
			window.meterObject.updateBaseURL('https://www.bostonglobe.com');
			
			window.meterObject.executeMeter({
				loid:'4.3.2988983448',
				uuid:'ae54edde-5df8-11e7-8b1b-beb6e0890464',
				
				exemptFromMeter: false
			});
			
		}

	})();
</script>
</body>
</html>

